MyCelx Technologies Corporation Dealings by Directors (1180S)
November 11 2021 - 5:51AM
UK Regulatory
TIDMMYX TIDMTTM
RNS Number : 1180S
MyCelx Technologies Corporation
11 November 2021
11 November 2021
Mycelx Technologies Corporation
("Mycelx" or the "Company" (AIM: MYX)
Dealings by Directors
The Company announces that it was notified on 11 November 2021
by Thomas Lamb, Chairman and a Director of the Company, that on 10
November 2021 he purchased 25,000 Common Shares at a price of
GBP0.72 per Common Share. Following this transaction, Mr Lamb is
interested in 25,000 Common Shares representing 0.13 per cent of
the present issued capital of the Company.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Canaccord Genuity, Nominated Adviser
Henry Fitzgerald-O'Connor Tel: + 44 20 7523 8000
Georgina McCooke
Celicourt
Mark Antelme Tel: +44 20 8434 2754
Jimmy Lea
Notifications of transactions of persons discharging managerial
responsibility or connected persons
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Thomas Lamb
---------------------------- ----------------------------------
2 Reason for the notification
----------------------------------------------------------------
a) Position/status Director
---------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
---------------------------- ----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------
a) Name Mycelx Technologies Corporation
---------------------------- ----------------------------------
b) LEI 213800UJZINIK2VD1G48
---------------------------- ----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
----------------------------------------------------------------
a) Description of the
financial instrument, Common shares of US$0.025
type of instrument
Identification code USU624551078
---------------------------- ----------------------------------
b) Nature of the transaction Purchase of Common Shares
---------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.72 25,000
----------
---------------------------- ----------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
---------------------------- ----------------------------------
e) Date of the transaction 10/11/2021
---------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange
---------------------------- ----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBBBBTMTIBBLB
(END) Dow Jones Newswires
November 11, 2021 06:51 ET (11:51 GMT)
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Jul 2023 to Jul 2024